Target intelligence / Profile preview

RNA, U6 small nuclear 701, pseudogene (RNU6-701P)

Target
RNU6-701P
Molecular classification
Other (Processed pseudogene; Small nuclear RNA pseudogene)
01

Overview

RNU6-701P is a processed pseudogene derived from the U6 small nuclear RNA (snRNA) gene family. The parental U6 snRNA is an essential component of the spliceosome, the molecular machinery responsible for removing introns from pre-mRNA during RNA splicing in the nucleus[1][3]. Pseudogenes like RNU6-701P arise in the genome via retrotransposition (often by L1 elements), generating inactive copies lacking regulatory elements or functional sequence integrity[2]. RNU6-701P does not code for a protein, nor does it act as a functional RNA; it serves as a genomic relic and may be used in research as a marker for retrotransposon activity[2]. There is no evidence for any functionality, involvement in disease, or relevance to drug targeting for this specific pseudogene. Any clinical or therapeutic relevance applies only to the functional U6 snRNA gene, not its pseudogenes[3][1]. If you are seeking a therapeutic, diagnostic, or mechanistic target, this entry is not suitable; it is a pseudogene, not a druggable molecule, receptor, or enzyme. If you need structured information for the functional U6 snRNA, refer to “U6 small nuclear RNA” (also called “U6 snRNA”).

Other names
RNU6-701PU6 snRNA pseudogeneU6 small nuclear RNA pseudogene
02

Mechanism of action

None

03

Biological functions

None (Pseudogenes typically do not encode functional molecules, although in rare cases some pseudogene transcripts may play regulatory roles as non-coding RNAs. For RNU6-701P, no evidence of a biological function is documented.)
04

Disease associations

None (No established disease association or function for this specific pseudogene[2][3].)
05

Safety considerations

None
06

Interacting drugs

None (Drugs do not target pseudogenes, including RNU6-701P.)
07

Biomarkers

None

Beyond the preview

Go deeper on RNA, U6 small nuclear 701, pseudogene (RNU6-701P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 701, pseudogene (RNU6-701P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call